CompletedNot Applicable

MenB Vaccine: Implementation Via Information, Empowerment and Accessibility

United States1,326 participantsStarted 2016-12

Plain-language summary

As part of an effort to increase MenB vaccine uptake among adolescents and young adults, study teams will conduct qualitative research to maximize the effectiveness of nationally recommended MenB educational materials. In this study, Study Teams will assess local barriers to MenB vaccination by conducting focus groups with parents, students, and health care professionals.

Who can participate

Age range16 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must be able to provide informed consent or assent Exclusion Criteria: * Inability to provide informed consent or assent

What they're measuring

Vaccine uptake in adolescents and young adults

Timeframe: 12 months

Knowledge about MenB vaccine efficacy, potential benefits, possible side effects

Timeframe: 12 months

Trial details

NCT IDNCT02975596

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-10-08

View on ClinicalTrials.gov More Meningococcal Vaccine trials